Is INGR a Good Stock to Buy? The Bull and Bear Case (2026)

Last updated November 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Ingredion Incorporated (INGR) rests on Corn costs pass through, so revenue and profit move separately: Bulk sweetener and starch volumes are sold on contracts that pass net corn costs to the customer, which means a fall in corn pulls reported revenue down without necessarily touching gross profit. The bear case rests on the thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date. Analysts covering it publish targets from $100.00 to $135.00 against a $92.96 share price on November 16, 2026, so even the professionals disagree by 31% of their own average. We do not give a verdict. Each case is set out below at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

INGR key stats

At $92.96 on November 16, 2026, Ingredion Incorporated (INGR) has a market cap of $5.8B, a P/E of 10.5 on trailing earnings (9.0 on forward earnings) and a dividend yield of 3.57%. It next reports earnings around February 2, 2027 (estimated).

Market cap
$5.8B
P/E (trailing)
10.5
P/E (forward)
9.0
EPS (trailing 12 months)
$8.81
Price to book
1.3
Dividend yield
3.57%
Beta
0.62
Next earnings
around February 2, 2027 (estimated)

Market cap, P/E and yield are measured at the $92.96 price on November 16, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Ingredion Incorporated (INGR)?

The last two weeks for Ingredion Incorporated, as of November 17, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • INGR closed at $92.96 on November 16, 2026, up 0.2% over the past five trading days (from $92.78).
  • Ingredion Incorporated next reports quarterly results around February 2, 2027 (estimated).
  • On November 6, 2026, Ingredion Incorporated filed its quarterly report (10-Q) with the SEC. Read the 10-Q on sec.gov
  • On November 5, 2026, Ingredion Incorporated filed an 8-K with the SEC reporting quarterly results (Item 2.02). Read the 8-K on sec.gov
  • On November 6, 2026, Stephens & Co. lowered its target to $100.00 from $105.00 (Equal-Weight).

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

Ingredion Incorporated grinds corn and other crops into starches, sweeteners and texturizing ingredients that end up inside packaged food, beverages, paper and pharmaceuticals. The business reports in three segments: Texture & Healthful Solutions, the global specialty texturant arm that produced ~$627 million of second quarter net sales; Food and Industrial Ingredients in Latin America, at ~$611 million; and Food and Industrial Ingredients in the US and Canada, at ~$488 million. A fourth bucket called All Other holds the PureCircle stevia, sugar reduction and pea protein fortification businesses. Trailing twelve month revenue runs about ~$7.2 billion on a market capitalisation near ~$6.2 billion as of October 2026, and the company has been reshaping the portfolio hard, closing its Cabo plant in Brazil and selling ~51% of its Pakistan subsidiary for ~$165 million in June 2026. The investment picture in 2026 is two stories running in opposite directions. Specialty volumes are growing and the US commodity segment is not, with US and Canada operating income down ~48% in the first half after a thermal event at the Argo facility in Illinois cost volumes and added manufacturing expense. Meanwhile management agreed in June to buy Tate & Lyle for 595 pence a share in cash, roughly ~£2.7 billion, a deal Tate & Lyle shareholders approved in late July and which is not expected to complete until the second half of 2027. That combination, a depressed commodity year and a large levered acquisition still 12 months from closing, is why the shares trade at a discount to the ingredient companies Ingredion wants to be compared with, and why the reported multiple looks cheaper than the risk profile. Since the second quarter report the stock has drifted lower. Second quarter adjusted EPS of ~$2.82 beat the ~$2.72 consensus, the first beat after three straight misses, but reported net income fell to ~$114 million from ~$142 million in the first quarter, and the shares closed at ~$98.52 on October 16, 2026, down ~10% year to date and ~18% over twelve months, close to the bottom of a ~$93.72 to ~$123.49 range. UBS trimmed its target to ~$104 from ~$108 in early October while keeping a neutral rating. Third quarter results are scheduled for November 5, 2026, with consensus near ~$2.61 of EPS on ~$1.8 billion of revenue, and the first read on whether Argo has normalised.

The bull case: what would have to be true for $135.00

The most optimistic published target on INGR is $135.00, +45.2% from the $92.96 share price on November 16, 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Corn costs pass through, so revenue and profit move separately

Bulk sweetener and starch volumes are sold on contracts that pass net corn costs to the customer, which means a fall in corn pulls reported revenue down without necessarily touching gross profit. Latin America demonstrated the mechanic in the first half of 2026, where net sales rose ~2% on currency while price mix fell specifically because raw material input costs fell. Reading Ingredion's top line as a demand signal will mislead more often than it informs, and the useful line is segment operating income.

2. Texture & Healthful Solutions carries the mix shift

The specialty texturant segment grew second quarter net sales ~5% to ~$627 million and lifted operating income ~5% to ~$117 million, while the US and Canada commodity segment fell ~33% to ~$58 million over the same three months. Specialty ingredients earn higher and steadier margins than high fructose corn syrup, so every point of mix shift improves the quality of earnings even when consolidated revenue is flat. Inside All Other, the protein fortification and stevia businesses swung from a small loss to ~$9 million of operating income year to date.

3. Tate & Lyle is that mix shift bought outright

Announced on June 8, 2026 and approved by Tate & Lyle shareholders on July 28, the all cash offer values the target's equity at approximately ~£2.7 billion, or about ~$3.5 billion at the June 30 rate. Tate & Lyle reported ~£2.0 billion of continuing revenue for its year ended March 2026, concentrated in sugar reduction, fibre and fortification, areas where Ingredion is currently sub scale. Management expects pro forma net leverage near ~3.0x adjusted EBITDA at completion and has committed to getting back toward ~2.5x within roughly 18 months, with financing already arranged through a ~$2.75 billion bridge and a ~$1.48 billion delayed draw term loan.

4. Cash generation still funds the dividend, but not the buyback

The 2026 guide calls for ~$700 million to ~$800 million of operating cash flow against ~$450 million to ~$490 million of capital spending, and the quarterly dividend stepped up to ~$0.82 in January for a yield near ~3.4% at the October 2026 price on a payout ratio around ~36%. Repurchases have effectively stopped ahead of the acquisition: only ~120 thousand shares were bought back in the first half at a cost of ~$14 million, against an authorisation covering 8.0 million shares through 2028. First half operating cash flow of ~$123 million ran well below the ~$262 million of a year earlier, largely on receivables build.

The bear case: what would have to be true for $100.00

The most pessimistic published target is $100.00, +7.6% from the current price. It is neither a floor nor a forecast; it is roughly what one analyst thinks Ingredion Incorporated is worth if the risks below bite instead of the drivers above.

The thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date. Funding Tate & Lyle takes net debt from roughly ~$0.8 billion today to about ~3.0x EBITDA at completion, and with closing not expected until the second half of 2027 there is a long window of antitrust review, integration planning and carrying cost before any synergy shows up. Second quarter financing costs jumped to ~$55 million mostly because of ~$47 million in hedging losses on the sterling consideration, so the currency exposure is already live even though the deal is not. Latin America supplies roughly a third of sales and carries Mexican peso translation risk plus what management called a more challenging demand environment. High fructose corn syrup consumption in North America is in slow secular decline, which the specialty growth has to outrun rather than merely offset. Analysts expect 2026 adjusted EPS of about ~$10.50, down ~6% on 2025, before a ~7% rebound to ~$11.25 in 2027, so the recovery case rests on the second half of this year.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding INGR already, these risks exist either way; what to check is whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on INGR

6 analysts cover INGR, with an average target of $113.17 (+21.7% against $92.96) and a split of 2 buy, 5 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the INGR forecast and price target page.

How is INGR valued?

Market cap, P/E and dividend yield at today's price are in the INGR key stats above. The business figures below come from Ingredion Incorporated's reported results as of October 2026 and change when it next reports.

  • Revenue (TTM): ~$7.2B (Q2 up ~1% YoY)
  • Net income (TTM): ~$592M (EPS ~$9.20)
  • Margins (gross / operating): ~23.7% / ~12.6%
  • FY 2026 adjusted EPS guidance: ~$10.30 to ~$10.90
  • Cash / debt (pre acquisition): ~$1.0B / ~$1.8B

As of October 2026: Near ~$98.50 a share on October 16, 2026 the stock carries about ~10.7 times trailing earnings, roughly ~9.4 times the midpoint of 2026 adjusted guidance and ~8.8 times next year's consensus, a visible discount to the branded specialty ingredient houses. That gap prices the commodity half of the business, the Argo disruption and the leverage still to arrive; the six covering analysts sit at hold with a mean target near ~$119.50. Reported and adjusted earnings diverge unusually far this year because of the Cabo closure charges, the ~$44 million Pakistan disposal gain and the acquisition hedges, so the ~$9.15 to ~$9.75 reported guide sits well below the ~$10.30 to ~$10.90 adjusted one.

How do you decide if INGR is a buy?

Whether INGR is a buy is easier to judge through four narrower questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold INGR indirectly through an index or sector ETF before adding more.

What would change your mind on INGR

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Corn costs pass through, so revenue and profit move separately stalls in the reported numbers. A shift in the narrative around them is not enough on its own.
  • Bear case breaks if: the thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the INGR stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about INGR against your real portfolio and see your actual exposure before deciding.

Your questions about Ingredion Incorporated

Ask Walnut's AI anything about INGR and see how it fits what you own.

FAQ

Is INGR a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Corn costs pass through, so revenue and profit move separately, with revenue (ttm) at ~$7.2B (Q2 up ~1% YoY). The bear case rests on the thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date. Analysts covering it are spread from $100.00 to $135.00, a spread wide enough to show the question is contested. If you believe the thesis, the questions that matter next are sizing and overlap; timing comes after. Walnut is not an investment adviser and this is not a recommendation.

Should I sell INGR?

+

Nobody can answer that for you, and a more useful version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date. If that risk is what you were worried about and it is now playing out, take it seriously. If the price simply fell while the thesis held, the situation is different. The most pessimistic published target is $100.00, +7.6% from the $92.96 price, which is one analyst's downside case. It is not a floor. Walnut is not an investment adviser.

What is the bull case for INGR?

+

Corn costs pass through, so revenue and profit move separately. Bulk sweetener and starch volumes are sold on contracts that pass net corn costs to the customer, which means a fall in corn pulls reported revenue down without necessarily touching gross profit. The most optimistic analyst target on INGR is $135.00, +45.2% from the $92.96 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for INGR?

+

The thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date. Funding Tate & Lyle takes net debt from roughly ~$0.8 billion today to about ~3.0x EBITDA at completion, and with closing not expected until the second half of 2027 there is a long window of antitrust review, integration planning and carrying cost before any synergy shows up. Second quarter financing costs jumped to ~$55 million mostly because of ~$47 million in hedging losses on the sterling consideration, so the currency exposure is already live even though the deal is not. Latin America supplies roughly a third of sales and carries Mexican peso translation risk plus what management called a more challenging demand environment. High fructose corn syrup consumption in North America is in slow secular decline, which the specialty growth has to outrun rather than merely offset. Analysts expect 2026 adjusted EPS of about ~$10.50, down ~6% on 2025, before a ~7% rebound to ~$11.25 in 2027, so the recovery case rests on the second half of this year. The most pessimistic published target is $100.00, +7.6% from the current price, which is roughly what one analyst thinks the stock is worth if these risks bite and the drivers do not.

What does Ingredion Incorporated do?

+

Ingredion turns corn and other crops into starches, sweeteners and texturizing ingredients sold to food, beverage and industrial manufacturers worldwide.

What would have to change for INGR to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Corn costs pass through, so revenue and profit move separately) stalling in the reported numbers (a change in the narrative alone does not count), the risk above (the thermal event at the Argo plant held back volumes and added manufacturing cost through the first half, cutting gross margin to ~23% from ~26% a year earlier and taking US and Canada segment operating income down ~48% year to date) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What does Ingredion actually make?

+

It processes corn and other crops into starches, sweeteners, texturizers and nutrition ingredients that go into packaged food, drinks, paper, adhesives and pharmaceuticals. Very little of it reaches a shelf under the Ingredion name. Customers are food and beverage manufacturers who buy on contract.

Why did revenue stay flat while profit fell in the first half of 2026?

+

Net sales were ~$3,642 million against ~$3,646 million a year earlier, but cost of sales rose ~4% on higher manufacturing costs and the Argo thermal event, pushing gross margin from ~26% to ~23%. Restructuring charges of ~$56 million tied to the Cabo, Brazil closure and ~$47 million of acquisition hedging losses did the rest. Net income attributable to Ingredion fell to ~$256 million from ~$393 million.

How exposed is Ingredion to corn prices?

+

Less than the raw material intensity suggests. Core sweetener and starch contracts pass net corn costs through to customers, so corn moves the revenue line in both directions without much effect on gross profit. What corn does influence is working capital and hedging, and the company runs commodity cash flow hedges against it.

Walnut is informational, not investment advice, and gives no verdict on INGR. Analyst targets referenced here come from a November 2026 pull of published third-party research and change constantly. The share price is the last one Yahoo Finance reported on November 16, 2026. Verify current figures with your broker before acting on them.

The case for and against similar stocks